TIMP3 and cholangiocarcinoma: Selaru et al. elegantly demonstrated that miR-21 is elevated in cholangiocarcinoma tissue samples and miR-21 inhibition increases TIMP3 protein expression in cholangiocarcinoma cell lines, but they did not explore the effects of miR‐21 over-expression on cell line behavior, and results were not confirmed in a murine model [20].